2-[(4-chlorophenyl)methoxy]benzoic acid, 95%, 500mg

2-(5-BROMO-2-FLUOROPHENYL)-1H-IMIDAZOLE, 95.0%, 250mg

(E)-3-(2-(7-chloroquinolin-2-yl)vinyl)benzaldehyde, 96%, 1g

3,3-Dimethyl-piperazin-2-one, 95.0%, 100g

2,2'-(1-Benzyl-2-phenylethylidene)bis((4S)-4-tert-butyl-4,5-dihydro-2-oxazole), 97%, 1g

2-(AZETIDIN-1-YL)ETHAN-1-AMINE, 95.0%, 5g

3-BROMO-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDIN-7-OL, 95.0%, 250mg

4-(1,3-thiazol-2-yl)butan-2-one, 95.0%, 250mg

4-NITROPHENYL 3-ETHYL-4-METHYL-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXYLATE, 95.0%, 100mg

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 1 - MWCO 6000 to 8000, 100 mm, 15 m, 1 Piece(s)

trans-2-Hexenyl Hexanoate>97.0%(GC)25mL

(S)-tert-Butyl 3-(prop-2-yn-1-yloxy)pyrrolidine-1-carboxylate, 250mg

4-Bromo-1-(difluoromethoxy)-2-methylbenzene, 95.0%, 5g